Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alicia, Terando"'
Autor:
Julie O. Culver, Yael Freiberg, Charité Ricker, Jacob G. Comeaux, Emmeline Y. Chang, Victoria Banerjee, Duveen Sturgeon, Ilana Solomon, Josie Kagey, Mariana G. Dobre, Joseph Carey, Azadeh Carr, Stephanie Cho, Janice Lu, Irene M. Kang, Ketan Patel, Alicia Terando, Jason C. Ye, Ming Li, Caryn Lerman, Darcy Spicer, Maria Nelson
Publikováno v:
Annals of Surgical Oncology. 30:1017-1025
The American Society of Breast Surgeons recommends genetic testing (GT) for all women with breast cancer (BC), but implementation and uptake of GT has not been well-described.A retrospective chart review was performed for newly diagnosed BC patients
Autor:
Julie O. Culver, Yael Freiberg, Charité Ricker, Jacob G. Comeaux, Emmeline Y. Chang, Victoria Banerjee, Duveen Sturgeon, Ilana Solomon, Josie Kagey, Mariana G. Dobre, Joseph Carey, Azadeh Carr, Stephanie Cho, Janice Lu, Irene M. Kang, Ketan Patel, Alicia Terando, Jason C. Ye, Ming Li, Caryn Lerman, Darcy Spicer, Maria Nelson
Publikováno v:
Annals of surgical oncology. 30(2)
Autor:
Nicholas Latchana, Zachary B Abrams, J Harrison Howard, Kelly Regan, Naduparambil Jacob, Paolo Fadda, Alicia Terando, Joseph Markowitz, Doreen Agnese, Philip Payne, William E Carson
Publikováno v:
Bioinformatics and Biology Insights, Vol 11 (2017)
Melanoma remains the leading cause of skin cancer–related deaths. Surgical resection and adjuvant therapies can result in disease-free intervals for stage III and stage IV disease; however, recurrence is common. Understanding microRNA (miR) dynamic
Externí odkaz:
https://doaj.org/article/8462b9cccd4e40d199f6d7207dc49148
Autor:
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Stephen Capone, Kathryn B Bollin, Daniel Y. Reuben, Keisuke Shirai, Sandy Zhang-Nunes, Omar Ragab, Alicia Terando, Jenny C. Hu, Han Lee, Shailender Bhatia, Sunandana Chandra, Jose Lutzky, Geoffrey Thomas Gibney
Publikováno v:
Journal for immunotherapy of cancer. 10(5)
BackgroundBasal cell carcinoma (BCC) is the most common malignancy worldwide, yet the management of patients with advanced or metastatic disease is challenging, with limited treatment options. Recently, programmed death receptor 1 (PD-1) inhibition h
Autor:
Gino K, In, Poorva, Vaidya, Alexandra, Filkins, David J, Hermel, Kevin G, King, Omar, Ragab, William W, Tseng, Mark, Swanson, Niels, Kokot, Julie E, Lang, Lawrence, Menendez, Brittney, DeClerck, Gene, Kim, Jenny C, Hu, Alicia, Terando, Hossein, Jadvar, Charité, Ricker, Kimberly A, Miller, David H, Peng, Ashley, Wysong
Publikováno v:
Journal of cancer research and clinical oncology. 147(6)
Approximately 5% of patients with cutaneous squamous cell carcinoma (CSCC) may develop recurrent or metastatic disease. The management of such cases is challenging and requires multi-disciplinary care. Immunotherapy using PD-1 inhibition was approved